http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014188775-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-721
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a2dd7cd660ae6ca1d6d5cfd445206d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_445dc0f6172803235abbcc7462a78971
publicationDate 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014188775-A1
titleOfInvention Method for preparing androgen receptor activity-dependent breast cancer cell line, screening method using cell line, and method, kit and marker for determining acquisition of androgen receptor activity dependence in breast cancer patient
abstract The present invention addresses the problem of providing a cell line having a novel resistance mechanism that is completely different from the resistance mechanisms in conventional hormone therapy, a screening method using the cell line, and a method for determining whether or not a breast cancer patient has acquired the aforesaid resistance mechanism.nProvided are: a method for preparing androgen receptor activity-dependent breast cancer cells, said method comprising a step for culturing T47D-TE8 cells in an estrogen-depleted medium in the presence of androgen; a screening method using the breast cancer cells; and a method and a kit for determining the presence or absence of the acquisition of androgen receptor activity dependence in a breast cancer patient with the use of at least one member selected from the group consisting of KLK3, DDC and AR as an indicator.
priorityDate 2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007099698-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012252748-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407902

Total number of triples: 32.